b'40#1 PRESCRIBED ONCE-MONTHLY LONG-ACTING INJECTABLE ATYPICAL ANTIPSYCHOTIC 1ITS ABOUT TIMEFOR THE TREATMENT OF SCHIZOPHRENIA IN ADULTSDONT WAIT UNTIL THERES NOTHING LEFT TO LOSEMissing doses of oral antipsychotics can cause repeated relapse. With each relapse comes the risk of losing the progress that you have made together. Clinical evidence is available in adults recently diagnosed with schizophrenia within 1 to 5 years 2*To view the data, simply scan this QR code or visit InvegaSustennaHCP.com Consider once-monthly INVEGA SUSTENNA earlier in the treatment journey.* All patients diagnosed 1 to 5 years previously with 2 relapses requiring hospitalization.INDICATIONINVEGA SUSTENNA (paliperidone palmitate) is indicated for the treatment of: Schizophrenia in adults.IMPORTANT SAFETY INFORMATION FOR INVEGA SUSTENNA (paliperidone palmitate)WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS.See full Prescribing Information for complete Boxed Warning.Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. INVEGA SUSTENNA is not approved for use in patients with dementia-related psychosis.Please see additional Important Safety Information and Brief Summary of the full Prescribing Information for INVEGA SUSTENNA on following pages of this advertisement.Actor Portrayal'